Telix Pharmaceuticals Ltd (TLX) stock
TLXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as TLPPF
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Feb 20, 2026Score 3/30
$8.96+0.11 (+1.19%)
Close on Nov 18, 2026Market cap $3.04BP/E –Yield –
Telix Pharmaceuticals operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
For fiscal 2025 it was -$17.29M, down 162.9% from the year before.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$17.29M | -162.9% |
| FY2024 | Dec 31, 2024 | $27.49M | +92.6% |
| FY2023 | Dec 31, 2023 | $14.27M | – |
See a number that looks wrong?